Electrically Assisted Movement Therapy
EAMT
1 other identifier
interventional
12
1 country
1
Brief Summary
The purpose of this study is to determine whether intensive, focused training of the affected upper extremity after stroke results in long-term functional gains in moderately-to-severely paralyzed patients, more than 6 months after their vascular accident. During the course of therapy, user's attempts to move and complete exercises are assisted by neuromuscular electrical stimulation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2015
CompletedFirst Submitted
Initial submission to the registry
September 22, 2015
CompletedFirst Posted
Study publicly available on registry
September 30, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedFebruary 24, 2016
February 1, 2016
1 year
September 22, 2015
February 23, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Fugl-Meyer Assessment of the Upper Extremity (FMA-UE),
A quantitative measure of motor impairment.
T0 (Before treatment); T1 (3 weeks after start and before treatment crossover); T2 (6 weeks after T0, at the end of treatment); T3 (3 months after treatment); T4 (6 months after treatment)
Secondary Outcomes (4)
Wolf Motor Function Test
T0 (Before treatment); T1 (3 weeks after start and before treatment crossover); T2 (6 weeks after T0, at the end of treatment); T3 (3 months after treatment); T4 (6 months after treatment)
Modified Ashworth scale
T0 (Before treatment); T1 (3 weeks after start and before treatment crossover); T2 (6 weeks after T0, at the end of treatment); T3 (3 months after treatment); T4 (6 months after treatment)
European stroke scale
T0 (Before treatment); T1 (3 weeks after start and before treatment crossover); T2 (6 weeks after T0, at the end of treatment); T3 (3 months after treatment); T4 (6 months after treatment)
Motor Activity Log
T0 (Before treatment); at 1, 2, 3, 4, 5, 6, 18 and 30 weeks after treatment start
Study Arms (2)
EAMT, then standard care
EXPERIMENTALElectrically Assisted Movement Therapy precedes usual and customary care.
Standard care, then EAMT
ACTIVE COMPARATORUsual and customary care precedes Electrically Assisted Movement Therapy.
Interventions
Electrically Assisted Movement Therapy (EAMT) is an extension of conventional Constraint-Induced Movement Therapy (CIMT) for moderately-to-severely paralyzed patients. During EAMT, patients use a movement controller with the healthy hand, controlling movements generated through neuromuscular electrical stimulation of the paralyzed arm and hand. During each session three types of exercises can be performed: mobilization, games, and training for activities of daily living, all three involving proper shaping of exercise difficulty at therapist discretion. Therapy consists in 20 sessions of 45 minutes twice per day over five weeks.
Usual and customary care ranges from no treatment to varying amounts of orthotics, home-based and clinic-based occupational therapy, or physiotherapy, but always excludes CIMT and EAMT. Therapy consists in 20 sessions of 45 minutes twice per day over five weeks, whenever possible, to match EAMT amount of therapy.
Eligibility Criteria
You may qualify if:
- Diagnosis of one, first ever stroke (both ischemic or hemorrhagic) verified by brain imaging (MRI or CT);
- Chronic impairment after stroke (minimum 6 months);
- No contraindications to MRI;
- No contraindications to electrical stimulation;
You may not qualify if:
- Unstable recovery stage (difference between two examinations \> 1 FMA-UE point);
- Mild impairment of the upper extremity (FMA-UE \>= 21);
- Excessive spasticity of the affected arm (modified Ashworth Scale \> 2);
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service de Neuropsychologie et neuroréhabilitation - CHUV
Lausanne, Canton of Vaud, 1011, Switzerland
Related Publications (1)
Carda S, Biasiucci A, Maesani A, Ionta S, Moncharmont J, Clarke S, Murray MM, Millan JDR. Electrically Assisted Movement Therapy in Chronic Stroke Patients With Severe Upper Limb Paresis: A Pilot, Single-Blind, Randomized Crossover Study. Arch Phys Med Rehabil. 2017 Aug;98(8):1628-1635.e2. doi: 10.1016/j.apmr.2017.02.020. Epub 2017 May 9.
PMID: 28499657DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stefano Carda, MD, PhD
Neuropsychology and Neurorehabilitation Service, Centre hospitalier universitaire vaudois (CHUV)
- STUDY DIRECTOR
José del R. Millán, Prof.
Defitech Foundation Chair in Brain-machine Interface, Swiss Federal Institute of Technology Lausanne (EPFL)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
September 22, 2015
First Posted
September 30, 2015
Study Start
September 1, 2015
Primary Completion
September 1, 2016
Study Completion
December 1, 2016
Last Updated
February 24, 2016
Record last verified: 2016-02
Data Sharing
- IPD Sharing
- Will not share